Methods of treating obesity and obesity-related conditions
TW202641829APending Publication Date: 2026-10-16AMGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145597
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-17
- Filing Date
- 2025-11-21
- Publication Date
- 2026-10-16
Smart Images
Figure 00000000_0000_ABST
Abstract
The present invention relates to methods of reducing weight, HbA1c levels, high-sensitivity C-reactive protein, and systolic blood pressure in human patients comprising administering to the patient maridebart cafraglutide with the result being treatment of obesity, type II diabetes, and other obesity related conditions such as atherosclerotic cardiovascular disease and heart failure.
Need to check novelty before this filing date? Find Prior Art